How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Jumbo CDs are much like regular CDs but bigger—sometimes a lot bigger Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, ...

Time-series spatial transcriptomics (ST) data can show dynamics of biological structures in situ. Here, the authors present an algorithm for cellular trajectory inference from time-series ST that ...